Vollmer Archives - Rocky Mountain MS Center

Immeasurabe Impact: Dr. Vollmer’s Career Highlights

By Rocky Mountain MS CenterInforMS: Winter 2021, Translational Lab

Instrumental in collaboration of international community of MS specialists in designing the first in-human trials for modern MS disease modifying therapies. Played key role with researchers across the world in…

November 15, 2021

Reflecting Back and Looking Ahead

By Kerri CechovicInforMS: Winter 2021, Translational Lab

Since 2008, Dr. Timothy Vollmer has not only been one of the primary neurologists seeing patients at the Rocky Mountain MS Center at University of Colorado, but has also served…

November 15, 2021

More From This Issue:

InforMS: Winter 2025

MS Research Today: Expanding Horizons

From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life. For...

InforMS: Winter 2025

Remembering Patricia Daily

We are saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from her...

InforMS: Winter 2025

BTK Inhibitors: A New Class Focused on Progression

A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But...

InforMS: Winter 2025

Lifestyle and Brain Health: What You Can Influence

One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical...

InforMS: Winter 2025

The Evolving Research of Discontinuing DMTs

One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they...

InforMS: Winter 2025

Moving the Needle: One Participant’s Journey Through MS Research

For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in...

InforMS: Winter 2025

Investing in Innovation: How Grassroots Research Funding Turns Bold Ideas into Better Care

Meaningful progress in multiple sclerosis research often begins with a single question. But those questions may not always fit the requirements of large federal or medical industry grants. Research that...

Click Here to Translate This Site »

Vollmer

Immeasurabe Impact: Dr. Vollmer’s Career Highlights

Reflecting Back and Looking Ahead

You're Reading:

Complete InforMS Archives

About the Author

More From This Issue:

MS Research Today: Expanding Horizons

From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life. For...

Remembering Patricia Daily

We are saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from her...

BTK Inhibitors: A New Class Focused on Progression

A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But...

Lifestyle and Brain Health: What You Can Influence

One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical...

The Evolving Research of Discontinuing DMTs

One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they...

Moving the Needle: One Participant’s Journey Through MS Research

For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in...

Investing in Innovation: How Grassroots Research Funding Turns Bold Ideas into Better Care

Meaningful progress in multiple sclerosis research often begins with a single question. But those questions may not always fit the requirements of large federal or medical industry grants. Research that...

ADVERTISEMENT

Contact Us

Mailing Address

The MS Center is coming to

Farmington, New Mexico!

Friday, May 16 | 5:30 to 7 p.m.

Vollmer

Share this:

Share this:

You're Reading:

About the Author

More From This Issue:

From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life. For...

We are saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from her...

A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But...

One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical...

One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they...

For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in...

Meaningful progress in multiple sclerosis research often begins with a single question. But those questions may not always fit the requirements of large federal or medical industry grants. Research that...

ADVERTISEMENT

Contact Us

Mailing Address